Listed

CorMedix Inc.

CRMDNasdaqCIK 1410098HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$101.9m, Q2 FY2026
Operating income$42.9m, Q2 FY2026
Net income$26.0m, Q2 FY2026
CorMedix Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reported0.8Revenue, Q2 FY2024, three months to 2024-06-30$806.1k. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure11.5Revenue, Q3 FY2024, three months to 2024-09-30$11.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure31.2Revenue, Q4 FY2024, three months to 2024-12-31$31.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure39.1Revenue, Q1 FY2025, three months to 2025-03-31$39.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure39.7Revenue, Q2 FY2025, three months to 2025-06-30$39.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure104Revenue, Q3 FY2025, three months to 2025-09-30$104.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure129Revenue, Q4 FY2025, three months to 2025-12-31$128.6m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure127Revenue, Q1 FY2026, three months to 2026-03-31$127.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure102Revenue, Q2 FY2026, three months to 2026-06-30$101.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Cost of revenue$mnot reportednot reported0.8Cost of revenue, Q1 FY2024, three months to 2024-03-31$818.5k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure0.5Cost of revenue, Q2 FY2024, three months to 2024-06-30$509.8k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure0.6Cost of revenue, Q3 FY2024, three months to 2024-09-30$634.6k. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure1.1Cost of revenue, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure1.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$1.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure1.9Cost of revenue, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure7.6Cost of revenue, Q3 FY2025, three months to 2025-09-30$7.6m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure11.2Cost of revenue, Q4 FY2025, three months to 2025-12-31$11.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure12.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$12.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figurenot reported
Gross profit$mnot reportednot reported(0.8)Gross profit, Q1 FY2024, three months to 2024-03-31−$818.5k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure0.3Gross profit, Q2 FY2024, three months to 2024-06-30$296.3k. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure10.8Gross profit, Q3 FY2024, three months to 2024-09-30$10.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure30.0Gross profit, Q4 FY2024, three months to 2024-12-31$30.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure37.5Gross profit, Q1 FY2025, three months to 2025-03-31$37.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure37.9Gross profit, Q2 FY2025, three months to 2025-06-30$37.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure93.1Gross profit, Q3 FY2025, three months to 2025-09-30$93.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure107Gross profit, Q4 FY2025, three months to 2025-12-31$107.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure105Gross profit, Q1 FY2026, three months to 2026-03-31$105.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure77.1Gross profit, Q2 FY2026, three months to 2026-06-30$77.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Research and development$m2.7Research and development, Q3 FY2023, three months to 2023-09-30$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figure2.3Research and development, Q4 FY2023, three months to 2023-12-31$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-25, accession 0001013762-25-001852. Derived: 12-month figure less the 9-month figure.Report this figure0.8Research and development, Q1 FY2024, three months to 2024-03-31$837.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure0.7Research and development, Q2 FY2024, three months to 2024-06-30$651.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure0.7Research and development, Q3 FY2024, three months to 2024-09-30$727.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure1.7Research and development, Q4 FY2024, three months to 2024-12-31$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure3.2Research and development, Q1 FY2025, three months to 2025-03-31$3.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure2.4Research and development, Q2 FY2025, three months to 2025-06-30$2.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure5.1Research and development, Q3 FY2025, three months to 2025-09-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure8.6Research and development, Q4 FY2025, three months to 2025-12-31$8.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure7.2Research and development, Q1 FY2026, three months to 2026-03-31$7.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure6.7Research and development, Q2 FY2026, three months to 2026-06-30$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Selling, general and administrative$m7.8Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$7.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2023-11-14, accession 0001213900-23-086981.Report this figure13.4Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$13.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2024-03-12, accession 0001213900-24-021585. Derived: 12-month figure less the 9-month figure.Report this figure15.0Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$15.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-05-09, accession 0001213900-24-041031.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(10.5)Operating income, Q3 FY2023, three months to 2023-09-30−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figure(15.7)Operating income, Q4 FY2023, three months to 2023-12-31−$15.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-25, accession 0001013762-25-001852. Derived: 12-month figure less the 9-month figure.Report this figure(16.7)Operating income, Q1 FY2024, three months to 2024-03-31−$16.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure(15.3)Operating income, Q2 FY2024, three months to 2024-06-30−$15.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure(3.3)Operating income, Q3 FY2024, three months to 2024-09-30−$3.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure12.9Operating income, Q4 FY2024, three months to 2024-12-31$12.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure20.1Operating income, Q1 FY2025, three months to 2025-03-31$20.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure19.5Operating income, Q2 FY2025, three months to 2025-06-30$19.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure51.3Operating income, Q3 FY2025, three months to 2025-09-30$51.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure59.1Operating income, Q4 FY2025, three months to 2025-12-31$59.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure63.7Operating income, Q1 FY2026, three months to 2026-03-31$63.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure42.9Operating income, Q2 FY2026, three months to 2026-06-30$42.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$13.1k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001213900-23-086981.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$6.6k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-12, accession 0001213900-24-021585. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$9.8k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001213900-24-041031.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$6.6k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-14, accession 0001213900-24-068600.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$10.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$9.6k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$10.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$6.7k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure0.9Interest expense, Q3 FY2025, three months to 2025-09-30$948.2k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure1.8Interest expense, Q4 FY2025, three months to 2025-12-31$1.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Income tax$mnot reportednot reported(1.4)Income tax, Q1 FY2024, three months to 2024-03-31−$1.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001213900-25-072843. Derived: 6-month figure less the 3-month figure.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001213900-25-108777. Derived: 9-month figure less the 6-month figure.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$230. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure0.5Income tax, Q2 FY2025, three months to 2025-06-30$522.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure(56.0)Income tax, Q3 FY2025, three months to 2025-09-30−$56.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure42.4Income tax, Q4 FY2025, three months to 2025-12-31$42.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure17.0Income tax, Q1 FY2026, three months to 2026-03-31$17.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure12.7Income tax, Q2 FY2026, three months to 2026-06-30$12.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Net income$m(9.7)Net income, Q3 FY2023, three months to 2023-09-30−$9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figure(14.8)Net income, Q4 FY2023, three months to 2023-12-31−$14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-25, accession 0001013762-25-001852. Derived: 12-month figure less the 9-month figure.Report this figure(14.5)Net income, Q1 FY2024, three months to 2024-03-31−$14.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure(14.2)Net income, Q2 FY2024, three months to 2024-06-30−$14.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure(2.8)Net income, Q3 FY2024, three months to 2024-09-30−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure13.5Net income, Q4 FY2024, three months to 2024-12-31$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure20.6Net income, Q1 FY2025, three months to 2025-03-31$20.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure19.8Net income, Q2 FY2025, three months to 2025-06-30$19.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure109Net income, Q3 FY2025, three months to 2025-09-30$108.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure14.0Net income, Q4 FY2025, three months to 2025-12-31$14.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure38.6Net income, Q1 FY2026, three months to 2026-03-31$38.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure26.0Net income, Q2 FY2026, three months to 2026-06-30$26.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Diluted EPS$ per share(0.17)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figurenot reported(0.25)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure(0.25)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure(0.05)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figurenot reported0.30Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure0.28Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure1.26Diluted EPS, Q3 FY2025, three months to 2025-09-30$1.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figurenot reported0.43Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure0.29Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Basic EPS$ per share(0.17)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figurenot reported(0.25)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure(0.25)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.25 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure(0.05)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figurenot reported0.32Basic EPS, Q1 FY2025, three months to 2025-03-31$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure0.29Basic EPS, Q2 FY2025, three months to 2025-06-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure1.42Basic EPS, Q3 FY2025, three months to 2025-09-30$1.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figurenot reported0.48Basic EPS, Q1 FY2026, three months to 2026-03-31$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure0.33Basic EPS, Q2 FY2026, three months to 2026-06-30$0.33 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure

Balance sheet

Cash and equivalents$256.7m, Q2 FY2026
Shareholders' equity$460.8m, Q2 FY2026
CorMedix Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m53.3Cash and equivalents, Q3 FY2023, at 2023-09-30$53.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figure43.6Cash and equivalents, FY2023, at 2023-12-31$43.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-25, accession 0001013762-25-001852.Report this figure35.2Cash and equivalents, Q1 FY2024, at 2024-03-31$35.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure28.5Cash and equivalents, Q2 FY2024, at 2024-06-30$28.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure35.3Cash and equivalents, Q3 FY2024, at 2024-09-30$35.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure40.7Cash and equivalents, FY2024, at 2024-12-31$40.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-05, accession 0001213900-26-023889.Report this figure66.3Cash and equivalents, Q1 FY2025, at 2025-03-31$66.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure159Cash and equivalents, Q2 FY2025, at 2025-06-30$159.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure48.5Cash and equivalents, Q3 FY2025, at 2025-09-30$48.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure145Cash and equivalents, FY2025, at 2025-12-31$144.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure178Cash and equivalents, Q1 FY2026, at 2026-03-31$178.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure257Cash and equivalents, Q2 FY2026, at 2026-06-30$256.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Current assets$m89.1Current assets, Q3 FY2023, at 2023-09-30$89.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001213900-23-086981.Report this figure79.5Current assets, FY2023, at 2023-12-31$79.5m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-25, accession 0001013762-25-001852.Report this figure63.4Current assets, Q1 FY2024, at 2024-03-31$63.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001213900-24-041031.Report this figure53.2Current assets, Q2 FY2024, at 2024-06-30$53.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-068600.Report this figure73.2Current assets, Q3 FY2024, at 2024-09-30$73.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figure115Current assets, FY2024, at 2024-12-31$114.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-05, accession 0001213900-26-023889.Report this figure145Current assets, Q1 FY2025, at 2025-03-31$144.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure248Current assets, Q2 FY2025, at 2025-06-30$248.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure260Current assets, Q3 FY2025, at 2025-09-30$259.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure367Current assets, FY2025, at 2025-12-31$367.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure383Current assets, Q1 FY2026, at 2026-03-31$383.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure481Current assets, Q2 FY2026, at 2026-06-30$480.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Total assets$m91.4Total assets, Q3 FY2023, at 2023-09-30$91.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001213900-23-086981.Report this figure82.1Total assets, FY2023, at 2023-12-31$82.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-25, accession 0001013762-25-001852.Report this figure68.0Total assets, Q1 FY2024, at 2024-03-31$68.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001213900-24-041031.Report this figure57.7Total assets, Q2 FY2024, at 2024-06-30$57.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001213900-24-068600.Report this figure77.6Total assets, Q3 FY2024, at 2024-09-30$77.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figure119Total assets, FY2024, at 2024-12-31$118.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-05, accession 0001213900-26-023889.Report this figure150Total assets, Q1 FY2025, at 2025-03-31$149.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure253Total assets, Q2 FY2025, at 2025-06-30$252.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure751Total assets, Q3 FY2025, at 2025-09-30$750.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure826Total assets, FY2025, at 2025-12-31$826.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure816Total assets, Q1 FY2026, at 2026-03-31$815.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure904Total assets, Q2 FY2026, at 2026-06-30$904.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Current liabilities$m7.7Current liabilities, Q3 FY2023, at 2023-09-30$7.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001213900-23-086981.Report this figure11.4Current liabilities, FY2023, at 2023-12-31$11.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-25, accession 0001013762-25-001852.Report this figure9.5Current liabilities, Q1 FY2024, at 2024-03-31$9.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001213900-24-041031.Report this figure11.1Current liabilities, Q2 FY2024, at 2024-06-30$11.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-068600.Report this figure18.5Current liabilities, Q3 FY2024, at 2024-09-30$18.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figure33.8Current liabilities, FY2024, at 2024-12-31$33.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-05, accession 0001213900-26-023889.Report this figure34.4Current liabilities, Q1 FY2025, at 2025-03-31$34.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure31.7Current liabilities, Q2 FY2025, at 2025-06-30$31.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure134Current liabilities, Q3 FY2025, at 2025-09-30$133.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure174Current liabilities, FY2025, at 2025-12-31$174.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure129Current liabilities, Q1 FY2026, at 2026-03-31$128.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure187Current liabilities, Q2 FY2026, at 2026-06-30$187.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Total liabilities$m8.2Total liabilities, Q3 FY2023, at 2023-09-30$8.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001213900-23-086981.Report this figure11.9Total liabilities, FY2023, at 2023-12-31$11.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-25, accession 0001013762-25-001852.Report this figure10.0Total liabilities, Q1 FY2024, at 2024-03-31$10.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001213900-24-041031.Report this figure11.5Total liabilities, Q2 FY2024, at 2024-06-30$11.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001213900-24-068600.Report this figure18.9Total liabilities, Q3 FY2024, at 2024-09-30$18.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figure34.2Total liabilities, FY2024, at 2024-12-31$34.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-05, accession 0001213900-26-023889.Report this figure34.7Total liabilities, Q1 FY2025, at 2025-03-31$34.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure32.0Total liabilities, Q2 FY2025, at 2025-06-30$32.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure377Total liabilities, Q3 FY2025, at 2025-09-30$376.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure421Total liabilities, FY2025, at 2025-12-31$420.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure379Total liabilities, Q1 FY2026, at 2026-03-31$378.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure443Total liabilities, Q2 FY2026, at 2026-06-30$443.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure
Shareholders' equity$m83.2Shareholders' equity, Q3 FY2023, at 2023-09-30$83.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figure70.1Shareholders' equity, FY2023, at 2023-12-31$70.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-05, accession 0001213900-26-023889.Report this figure58.0Shareholders' equity, Q1 FY2024, at 2024-03-31$58.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure46.2Shareholders' equity, Q2 FY2024, at 2024-06-30$46.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure58.7Shareholders' equity, Q3 FY2024, at 2024-09-30$58.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure84.7Shareholders' equity, FY2024, at 2024-12-31$84.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure115Shareholders' equity, Q1 FY2025, at 2025-03-31$114.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure221Shareholders' equity, Q2 FY2025, at 2025-06-30$220.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure374Shareholders' equity, Q3 FY2025, at 2025-09-30$374.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure405Shareholders' equity, FY2025, at 2025-12-31$405.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure437Shareholders' equity, Q1 FY2026, at 2026-03-31$437.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure461Shareholders' equity, Q2 FY2026, at 2026-06-30$460.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure

Cash flow

Operating cash flow$86.2m, Q2 FY2026
Capital expenditure$561.0k, Q2 FY2026
Share repurchases$6.4m, Q2 FY2026
CorMedix Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(8.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$8.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-30, accession 0001213900-24-091961. Derived: 9-month figure less the 6-month figure.Report this figure(10.7)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$10.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-25, accession 0001013762-25-001852. Derived: 12-month figure less the 9-month figure.Report this figure(17.3)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$17.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure(14.0)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001213900-25-072843. Derived: 6-month figure less the 3-month figure.Report this figure(13.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$13.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001213900-25-108777. Derived: 9-month figure less the 6-month figure.Report this figure(5.6)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$5.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure19.7Operating cash flow, Q1 FY2025, three months to 2025-03-31$19.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure30.0Operating cash flow, Q2 FY2025, three months to 2025-06-30$30.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001410098-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure30.9Operating cash flow, Q3 FY2025, three months to 2025-09-30$30.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001213900-25-108777. Derived: 9-month figure less the 6-month figure.Report this figure94.5Operating cash flow, Q4 FY2025, three months to 2025-12-31$94.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure42.4Operating cash flow, Q1 FY2026, three months to 2026-03-31$42.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure86.2Operating cash flow, Q2 FY2026, three months to 2026-06-30$86.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001410098-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$10.2k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-30, accession 0001213900-24-091961. Derived: 9-month figure less the 6-month figure.Report this figure0.3Capital expenditure, Q4 FY2023, three months to 2023-12-31$295.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-25, accession 0001013762-25-001852. Derived: 12-month figure less the 9-month figure.Report this figure0.1Capital expenditure, Q1 FY2024, three months to 2024-03-31$61.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$34.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001213900-25-072843. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$9.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001213900-25-108777. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$10.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure0.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$24.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001410098-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure0.5Capital expenditure, Q3 FY2025, three months to 2025-09-30$505.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001213900-25-108777. Derived: 9-month figure less the 6-month figure.Report this figure1.7Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001213900-26-023889. Derived: 12-month figure less the 9-month figure.Report this figure0.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$729.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure0.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$561.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001410098-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Share repurchases, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure0.0Share repurchases, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-13, accession 0001410098-26-000056. Derived: 6-month figure less the 3-month figure.Report this figurenot reportednot reported11.1Share repurchases, Q1 FY2026, three months to 2026-03-31$11.1m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure6.4Share repurchases, Q2 FY2026, three months to 2026-06-30$6.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-13, accession 0001410098-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)92.48m, Q2 FY2026
CorMedix Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares41.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3041,183,585 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001213900-23-086981.Report this figure44.1Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3144,090,998 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001213900-24-041031.Report this figure45.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3045,365,635 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001213900-24-068600.Report this figure56.6Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3056,553,174 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-30, accession 0001213900-24-091961.Report this figure57.5Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3157,503,154 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0001213900-25-039908.Report this figure57.6Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3057,620,974 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001213900-25-072843.Report this figure58.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3058,825,221 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure69.0Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3168,975,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure71.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3071,919,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure86.2Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3086,214,170 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001213900-25-108777.Report this figure93.0Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3192,985,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001410098-26-000021.Report this figure92.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3092,479,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure

Shares outstanding: 77.94mShares outstanding, period not labelled, at 2026-08-1077,944,324 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001410098-26-000056.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. Listed shows no prices and gives no investment advice.